Well I told my doctor about this company and the feedback I got that was based on the AGM report was that Glass and Garners CVs are impressive. Also that INV102 would be off to a good start with a known safety profile but that Cpn10 was the most interesting. I guess I have a personal interest as I have bronchitis from time to time and INV102 sounds good to me. I wish it had been on the market 2 months ago. So where is the news? 2 not 1 - Two trials commencing by end of 2012? Questions to be answered - 1. Have all the required candidates for the trials been enrolled? 2.Have the trials commenced? If so when and where? 3. Estimated end dates of trials, data collection and results. I would have thought we would have been getting a steady trickle of announcements re progress on these. I will send an email to Investor Relations and let you know if I receive a reply.
IVX Price at posting:
4.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)